Drug Side Effects
Search
LINEAGE SWITCH LEUKAEMIA
LINEAGE SWITCH LEUKAEMIA
was reported 53 times
LINEAGE SWITCH LEUKAEMIA is most prevalent among patients taking these drug classes:
#
Drug class
Count
Frequency
0
CD22-directed Immunoconjugate [EPC]
9
0.0030
1
CD33-directed Immunoconjugate [EPC]
2
0.0005
2
Topoisomerase Inhibitor [EPC]
6
0.0001
3
Asparagine-specific Enzyme [EPC]
1
0.0001
4
Vasopressin V2 Receptor Antagonist [EPC]
1
0.0001
5
Nucleoside Metabolic Inhibitor [EPC]
17
0.0001
6
Alkylating Drug [EPC]
14
0.0001
7
BCL-2 Inhibitor [EPC]
2
0.0000
8
Peroxisome Proliferator Receptor alpha Agonist [EPC]
1
0.0000
9
Folate Analog Metabolic Inhibitor [EPC]
7
0.0000
10
Interleukin-6 Receptor Antagonist [EPC]
2
0.0000
11
Corticosteroid [EPC]
16
0.0000
12
Purine Antimetabolite [EPC]
1
0.0000
13
Sodium-Glucose Cotransporter 2 Inhibitor [EPC]
1
0.0000
14
Calcineurin Inhibitor Immunosuppressant [EPC]
1
0.0000
15
Serotonin-3 Receptor Antagonist [EPC]
1
0.0000
16
Leukocyte Growth Factor [EPC]
1
0.0000
17
Aldosterone Antagonist [EPC]
1
0.0000
18
Azole Antifungal [EPC]
1
0.0000
19
Vascular Endothelial Growth Factor Inhibitor [EPC]
1
0.0000
20
Nonsteroidal Anti-inflammatory Drug [EPC]
1
0.0000